These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31344228)

  • 1. Avoiding Unnecessary Treatment of Cervical Intraepithelial Neoplasia Grade 2.
    Del Mistro A
    Clin Infect Dis; 2020 Jun; 70(12):2591-2592. PubMed ID: 31344228
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 Methods in Diagnosing Cervical Intraepithelial Neoplasia Grade 2+ in Xinjiang Uyghur Women.
    Tuerxun G; Yukesaier A; Lu L; Aierken K; Mijiti P; Jiang Y; Abulizi A; Zhang Y; Abuduxikuer G; Abulizi G; Li H
    Oncologist; 2016 Jul; 21(7):825-31. PubMed ID: 27317575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.
    Ibáñez R; Moreno-Crespi J; Sardà M; Autonell J; Fibla M; Gutiérrez C; Lloveras B; Alejo M; Català I; Alameda F; Casas M; Bosch FX; de Sanjosé S
    BMC Infect Dis; 2012 Jan; 12():25. PubMed ID: 22280073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical performance of DNA and RNA based HPV tests for test of cure (TOC) post treatment for cervical intraepithelial neoplasia (CIN) - a retrospective study.
    Bhatia R; Graham C; Elasifer H; Asodaria P; Moncur S; Wilson A; Palmer T; Cuschieri K
    J Clin Virol; 2022 Jun; 150-151():105165. PubMed ID: 35487094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
    Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
    J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active surveillance as a management option for cervical intraepithelial neoplasia 2: An online experimental study.
    Dodd RH; Cvejic E; Bell K; Black K; Bateson D; Smith MA; Mac OA; McCaffery KJ
    Gynecol Oncol; 2021 Apr; 161(1):179-187. PubMed ID: 33516531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions.
    Iwata T; Hasegawa T; Ochiai K; Takizawa K; Umezawa S; Kuramoto H; Ohmura M; Kubushiro K; Arai H; Sakamoto M; Motoyama T; Watanabe K; Aoki D
    Reprod Sci; 2015 Dec; 22(12):1509-15. PubMed ID: 26092278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
    Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
    Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16INK4a and low-grade cervical intraepithelial neoplasia. Diagnostic and therapeutic implications.
    Di Stefano L; Accurti V; Coletti G; D'Alfonso A; Carta G
    Eur J Gynaecol Oncol; 2010; 31(4):411-4. PubMed ID: 20882883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
    De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
    Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
    JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial.
    Verhoef VM; Bosgraaf RP; van Kemenade FJ; Rozendaal L; Heideman DA; Hesselink AT; Bekkers RL; Steenbergen RD; Massuger LF; Melchers WJ; Bulten J; Overbeek LI; Berkhof J; Snijders PJ; Meijer CJ
    Lancet Oncol; 2014 Mar; 15(3):315-22. PubMed ID: 24529697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic value of p16/mcm2 dual staining in cervical intraepithelial neoplasia and its association with high-risk HPV infection].
    Wang HR; Liao GD; Jiang Y; Li YC; Qiao YL; Chen W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1241-1245. PubMed ID: 28910940
    [No Abstract]   [Full Text] [Related]  

  • 14. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
    Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttreatment assessment of women at risk of developing high-grade cervical disease: proposal for new guidelines based on data from the Netherlands.
    Uijterwaal MH; Kocken M; Berkhof J; Bekkers RL; Verheijen RH; Helmerhorst TJ; Meijer CJ
    J Low Genit Tract Dis; 2014 Oct; 18(4):338-43. PubMed ID: 24769656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial Neoplasia.
    Crosbie EJ; Bailey A; Sargent A; Gilham C; Peto J; Kitchener HC
    J Clin Microbiol; 2015 Nov; 53(11):3553-9. PubMed ID: 26338859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial.
    Denny L; Kuhn L; Hu CC; Tsai WY; Wright TC
    J Natl Cancer Inst; 2010 Oct; 102(20):1557-67. PubMed ID: 20884893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of commercial HPV assays in the context of post-treatment follow-up: Scottish Test of Cure Study (STOCS-H).
    Cubie HA; Canham M; Moore C; Pedraza J; Graham C; Cuschieri K
    J Clin Pathol; 2014 Jun; 67(6):458-63. PubMed ID: 24436334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.